Janux Therapeutics’ $193.8 Million IPO

Wilson Sonsini Goodrich & Rosati advised Janux Therapeutics, Inc. on the deal, while Latham & Watkins LLP represented the underwriters. Janux Therapeutics, Inc., a biopharmaceutical company…

This content is for members only.
Login to Read More Join Now
Avatar

Author: admin

This content is for members only.
Login to Read More Join Now